Search research articles
Contact Us
Filters
Showing results (101-110 of 221) with videos related to
Page
of 23
Sort By:
Calcified Tissue International
|
December 3, 2009
Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone
Matthew R Allen, Antonia M Erickson, Xiang Wang, et al.
Journal of Biomechanics
|
March 17, 2009
Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage
Xiang Wang, Antonia M Erickson, Matthew R Allen, et al.
Cureus
|
July 7, 2023
Return to Sport Using Corticosteroid Injections for Knee Pain in Triathletes
Mackenzie B Norman, Emily R Norman, Gregory H Langer, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
February 2, 2022
Diversifying Faculty Leadership in Academic Medicine: The Program to Launch Underrepresented in Medicine Success (PLUS)
Brownsyne Tucker Edmonds, Alvaro J Tori, Amy K Ribera, et al.
Endocrinology
|
May 5, 2007
Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone
Matthew R Allen, Harry A Hogan, Wesley A Hobbs, et al.
JAMA Internal Medicine
|
February 17, 2025
Growing Health Concern Regarding Gambling Addiction in the Age of Sportsbooks
Atharva Yeola, Matthew R Allen, Nimit Desai, et al.
Bone
|
October 8, 2021
The combination of aging and chronic kidney disease leads to an exacerbated cortical porosity phenotype
Samantha P Tippen, Corinne E Metzger, Elizabeth A Swallow, et al.
Equine Veterinary Journal
|
June 26, 2024
Clinically relevant doses of tiludronate do not affect bone remodelling in pasture-exercised horses
Samantha P Tippen, Corinne E Metzger, Spencer A Sacks, et al.
Bone
|
April 21, 2015
Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions
Christopher L Newman, Neal X Chen, Eric Smith, et al.
Bone
|
January 27, 2022
Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease
Elizabeth A Swallow, Corinne E Metzger, Christopher L Newman, et al.
Page
of 23
Search research articles
Search
Showing results (101-110 of 221) with videos related to
Sort By:
Page
of 23
Calcified Tissue International
|
December 3, 2009
Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone
Matthew R Allen, Antonia M Erickson, Xiang Wang, et al.
Journal of Biomechanics
|
March 17, 2009
Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage
Xiang Wang, Antonia M Erickson, Matthew R Allen, et al.
Cureus
|
July 7, 2023
Return to Sport Using Corticosteroid Injections for Knee Pain in Triathletes
Mackenzie B Norman, Emily R Norman, Gregory H Langer, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
February 2, 2022
Diversifying Faculty Leadership in Academic Medicine: The Program to Launch Underrepresented in Medicine Success (PLUS)
Brownsyne Tucker Edmonds, Alvaro J Tori, Amy K Ribera, et al.
Endocrinology
|
May 5, 2007
Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone
Matthew R Allen, Harry A Hogan, Wesley A Hobbs, et al.
JAMA Internal Medicine
|
February 17, 2025
Growing Health Concern Regarding Gambling Addiction in the Age of Sportsbooks
Atharva Yeola, Matthew R Allen, Nimit Desai, et al.
Bone
|
October 8, 2021
The combination of aging and chronic kidney disease leads to an exacerbated cortical porosity phenotype
Samantha P Tippen, Corinne E Metzger, Elizabeth A Swallow, et al.
Equine Veterinary Journal
|
June 26, 2024
Clinically relevant doses of tiludronate do not affect bone remodelling in pasture-exercised horses
Samantha P Tippen, Corinne E Metzger, Spencer A Sacks, et al.
Bone
|
April 21, 2015
Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions
Christopher L Newman, Neal X Chen, Eric Smith, et al.
Bone
|
January 27, 2022
Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease
Elizabeth A Swallow, Corinne E Metzger, Christopher L Newman, et al.
Page
of 23